Bioregenx (BRGX) Accounts Payables (2021 - 2026)
Bioregenx (BRGX) recorded quarterly Accounts Payables of $698974.0 in Q1 2026, up 13.47% quarter-over-quarter from $615990.0 in Q4 2025, and up 869.98% on a YoY basis from $72061.0 in Q1 2025.
Bioregenx (BRGX) Accounts Payables (2021 - 2026) Analysis & Trends
Bioregenx's Accounts Payables history runs 6 years deep, the most recent figure standing at $698974.0 for Q1 2026.
- In Q1 2026, Accounts Payables rose 869.98% year-over-year to $698974.0; the TTM figure through Mar 2026 stood at $698974.0 (up 869.98% YoY), while the FY2025 annual figure was $615990.0, up 44.1% from the prior year.
- Accounts Payables was $698974.0 for Q1 2026 at Bioregenx, up from $615990.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $698974.0 in Q1 2026 to a low of $19721.0 in Q4 2022.
- Historically, Accounts Payables has averaged $319514.6 across 5 years, with a median of $399167.5 in 2024.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables soared 1784.61% in 2024, then tumbled 80.57% in 2025.
- A 5-year view of Accounts Payables shows it stood at $19721.0 in 2022, then surged by 1125.57% to $241695.0 in 2023, then surged by 76.87% to $427478.0 in 2024, then surged by 44.1% to $615990.0 in 2025, then advanced by 13.47% to $698974.0 in 2026.
- The last three Accounts Payables figures came in at $698974.0 (Q1 2026), $615990.0 (Q4 2025), and $459652.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 40.66 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 1.09 Bn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 14.22 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 69.48 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 17.43 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 4.01 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 58.80 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 80.56 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 58.34 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | 698,974.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 698,974.00 |
| Dec 31, 2025 | 615,990.00 |
| Sep 30, 2025 | 459,652.00 |
| Jun 30, 2025 | 568,799.00 |
| Mar 31, 2025 | 72,061.00 |
| Dec 31, 2024 | 427,478.00 |
| Sep 30, 2024 | 492,713.00 |
| Jun 30, 2024 | 431,810.00 |
| Mar 31, 2024 | 370,857.00 |
| Dec 31, 2023 | 241,695.00 |
| Sep 30, 2023 | 26,144.00 |
| Jun 30, 2023 | 24,978.00 |
| Mar 31, 2023 | 22,333.00 |
| Dec 31, 2022 | 19,721.00 |
| Dec 31, 2021 | 11,996.00 |